These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 745682)

  • 1. Behavioural effects of neonatal systemic 6-hydroxydopamine.
    Saari M; Pappas BA
    Neuropharmacology; 1978 Oct; 17(10):863-71. PubMed ID: 745682
    [No Abstract]   [Full Text] [Related]  

  • 2. Neonatal 6-hydroxydopamine sympathectomy reduces foot shock-induced suppression of water-licking in normotensive and hypertensive rats.
    Saari M; Pappas BA
    Nat New Biol; 1973 Aug; 244(136):181-3. PubMed ID: 4516452
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 4. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 5. 3-methoxy-4-hydroxyphenylglycol excretion and behavioural changes in rat and monkey after central sympathecomy with 6-hydroxydopamine.
    Breese GR; Prange AJ; Howard JL; Lipton MA; McKinney WT; Bowman RE; Bushnell P
    Nat New Biol; 1972 Dec; 240(104):286-7. PubMed ID: 4633263
    [No Abstract]   [Full Text] [Related]  

  • 6. Operant behavioural and neurochemical effects after neonatal 6-hydroxydopamine treatment.
    Peterson DW; Laverty R
    Psychopharmacology (Berl); 1976 Oct; 50(1):55-60. PubMed ID: 13445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neonatal 6-hydroxydopamine treatment on catecholamine levels and behavior during development and adulthood.
    Fobes JL; Olds ME
    Psychopharmacology (Berl); 1981; 73(1):27-30. PubMed ID: 6785785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural effects of methylphenidate in 6-hydroxydopamine-treated neonatal rats.
    Eastgate SM; Wright JJ; Werry JS
    Psychopharmacology (Berl); 1978 Jul; 58(2):157-9. PubMed ID: 98783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of the post-decapitation convulsion in the rat: effects of neonatal systemic 6-hydroxydopamine.
    Saari M; Ings R; Pappas BA
    Neuropharmacology; 1978 Oct; 17(10):873-7. PubMed ID: 745683
    [No Abstract]   [Full Text] [Related]  

  • 10. Deficits in instrumental responding after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection.
    Fibiger HC; Phillips AG; Zis AP
    Pharmacol Biochem Behav; 1974; 2(1):87-96. PubMed ID: 4151316
    [No Abstract]   [Full Text] [Related]  

  • 11. Central effects of 6-hydroxydopamine.
    De Carolis AS; Ziegler H; Del Basso P; Longo VG
    Physiol Behav; 1971 Nov; 7(5):705-8. PubMed ID: 5170825
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of intra-amygdaloid injections of 6-hydroxy-dopamine on avoidance responding in rats.
    Ashford J; Jones BJ
    Br J Pharmacol; 1976 Mar; 56(3):255-61. PubMed ID: 1260169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlordiazepoxide-induced released responding in extinction and punishment-conflict procedures is not altered by neonatal forebrain norepinephrine depletion.
    Bialik RJ; Pappas BA; Pusztay W
    Pharmacol Biochem Behav; 1982 Feb; 16(2):279-83. PubMed ID: 7071081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confounding effects of procaine hydrochloride and adequate baseline on conditioned drinking.
    Wayner MJ; Fraley S
    Pharmacol Biochem Behav; 1973; 1(5):551-6. PubMed ID: 4790735
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of thyrotropin-releasing hormone on locomotor activity, operant performance and ingestive behavior.
    Vogel RA; Cooper BR; Barlow TS; Prange AJ; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1979 Feb; 208(2):161-8. PubMed ID: 105126
    [No Abstract]   [Full Text] [Related]  

  • 16. Neonatal sympathectomy by 6-hydroxydopamine in the rat: no effects on behavior by changes in endogenous brain norepinephrine.
    Pappas BA; Sobrian SK
    Life Sci I; 1972 Jul; 11(14):653-9. PubMed ID: 4656097
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavior and neurochemical changes following administration of 6-hydroxydopamine into the ventral tegmental area of the midbrain.
    Nakamura K; Nakamura K
    Jpn J Pharmacol; 1976 Apr; 26(2):269-73. PubMed ID: 945851
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired acquisition of an operant response in young rats depleted of brain dopamine in neonatal life.
    Heffner TG; Seiden LS
    Psychopharmacology (Berl); 1983; 79(2-3):115-9. PubMed ID: 6405418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phenobarbital on activity and learning in 6-hydroxydopamine treated rat pups.
    Shaywitz BA; Pearson DA
    Pharmacol Biochem Behav; 1978 Aug; 9(2):173-9. PubMed ID: 714967
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of 6-hydroxydopamine and 6-hydroxydopa on development of behavior.
    Morgan DN; McLean JH; Kostrzewa RM
    Pharmacol Biochem Behav; 1979 Sep; 11(3):309-12. PubMed ID: 504311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.